COVID-19 vaccine boosters that target the Omicron virus variant may not be needed, according to a new study.
Researchers with the National Institutes of Health (NIH), Moderna, and other institutions tested Moderna’s regular booster and Moderna’s Omicron-specific booster and found that both lead to “comparable and significant increases in neutralizing antibody responses against all VOC including Omicron.”
